Herbal composition and process for its preparation
    1.
    发明授权
    Herbal composition and process for its preparation 失效
    草药成分及其制备方法

    公开(公告)号:US08137708B2

    公开(公告)日:2012-03-20

    申请号:US12520198

    申请日:2007-02-20

    IPC分类号: A01N65/00

    摘要: A herbal composition comprising a therapeutically effective amount of the extract of Piper betle leaves as an active ingredient either alone, or with a pharmaceutically acceptable excipient. A process for the preparation of the herbal composition is provided. The herbal composition is adapted for the treatment of chronic myeloid leukemia (CML; chronic myelogenous leukemia) showing resistance to treatment with imatinib (Gleevec® or Glivec®).

    摘要翻译: 一种草药组合物,其包含治疗有效量的Pi叶提取物作为单独的活性成分或与药学上可接受的赋形剂。 提供了一种制备草药组合物的方法。 草药组合物适用于治疗显示对伊马替尼治疗(Gleevec或Glivec)的抗性的慢性骨髓性白血病(CML;慢性骨髓性白血病)。

    HERBAL COMPOSITION AND PROCESS FOR ITS PREPARATION
    2.
    发明申请
    HERBAL COMPOSITION AND PROCESS FOR ITS PREPARATION 失效
    草本组合物及其制备方法

    公开(公告)号:US20100028472A1

    公开(公告)日:2010-02-04

    申请号:US12520198

    申请日:2007-02-20

    IPC分类号: A61K36/00 A61P35/02

    摘要: A herbal composition comprising a therapeutically effective amount of the extract of Piper betle leaves as an active ingredient either alone, or with a pharmaceutically acceptable excipient. A process for the preparation of the herbal composition is provided. The herbal composition is adapted for the treatment of chronic myeloid leukemia (CML; chronic myelogenous leukemia) showing resistance to treatment with imatinib (Gleevec® or Glivec®).

    摘要翻译: 一种草药组合物,其包含治疗有效量的Pi叶提取物作为单独的活性成分或与药学上可接受的赋形剂。 提供了一种制备草药组合物的方法。 草药组合物适用于治疗显示对用伊马替尼治疗(Gleevec或Glivec)的抗性的慢性骨髓性白血病(CML;慢性骨髓性白血病)。